Calian Group Ltd (CGY.TO)
Investor Insights
Jun 5, 2026, 12:00 am This summary was created by AI, based on 1 opinions in the last 12 months.
Calian Group Ltd (CGY-T) has showcased a strong performance recently, achieving a notable milestone by hitting a 52-week high. Experts are optimistic about its prospects, highlighting the company's solid operational strategies and momentum in the market. The latest quarterly results have been described as satisfactory, leading to a favorable outlook for investors. Many view the company as well-managed and believe that it remains a worthwhile asset to hold in a diversified portfolio. Overall, the consensus points towards continued confidence in the company's trajectory and prospects for future growth.
Calian Group Ltd (CGY.TO) Frequently Asked Questions
What is Calian Group Ltd stock symbol?
Calian Group Ltd is a Canadian stock, trading under the symbol CGY.TO (previously CGY-T on Stockchase) on the Toronto Stock Exchange (CGY-CT). It is usually referred to as TSX:CGY or CGY.TO
Is Calian Group Ltd a buy or a sell?
In the last year, 1 stock analyst published opinions about CGY.TO (previously CGY-T on Stockchase). 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Calian Group Ltd.
Is Calian Group Ltd a good investment or a top pick?
Calian Group Ltd was recommended as a Top Pick by Jean-Francois Tardif on 2007-01-10. Read the latest stock experts ratings for Calian Group Ltd.
Why is Calian Group Ltd stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is Calian Group Ltd worth watching?
1 stock analyst on Stockchase covered Calian Group Ltd in the last year. It is a trending stock that is worth watching.
What is Calian Group Ltd stock price?
On 2026-06-05, Calian Group Ltd (CGY.TO) stock closed at a price of $85.08.
It does 145 pharmacies by Loblaw’s (L-T) and medical services for the Canadian Defence Department, as well as a satellite business out of Saskatoon. One of the most consistently profitable small-cap companies for the last 5 years. 4% dividend yield. (Analysts’ price target is $31.00.)